Planet 13 Holdings (PLNH) Research & Development (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Research & Development of $1.2 million for Q1 2026, down 22.36% year-over-year from $1.5 million in Q1 2025, and up 7.87% quarter-over-quarter from $1.1 million in Q4 2025.
Planet 13 Holdings (PLNH) Research & Development (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Research & Development for 6 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 22.36% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $5.1 million (down 15.68% YoY), while the FY2025 annual figure was $5.5 million, down 6.0% from the prior year.
- Research & Development climbed to $1.2 million in Q1 2026 per PLNH's latest filing, from $1.1 million in the prior quarter.
- Across five years, Research & Development topped out at $1.6 million in Q2 2025 and bottomed at $603242.0 in Q1 2022.
- Historically, Research & Development has averaged $1.3 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2022 — Research & Development plunged 52.12% — and 2023, when it jumped 121.43%.
- Planet 13 Holdings' Research & Development stood at $1.1 million in 2022, then advanced by 25.72% to $1.4 million in 2023, then grew by 5.39% to $1.4 million in 2024, then slipped by 21.85% to $1.1 million in 2025, then grew by 7.87% to $1.2 million in 2026.
- Business Quant data shows PLNH's Research & Development at $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 938,269.00 |
| Jun 30, 2022 | 887,436.00 |
| Mar 31, 2022 | 603,242.00 |
| Dec 31, 2021 | 1.81 Mn |
| Sep 30, 2021 | 1.96 Mn |